181 related articles for article (PubMed ID: 25123131)
1. A combination of eicosapentaenoic acid-free fatty acid, epigallocatechin-3-gallate and proanthocyanidins has a strong effect on mTOR signaling in colorectal cancer cells.
D'Angelo L; Piazzi G; Pacilli A; Prossomariti A; Fazio C; Montanaro L; Graziani G; Fogliano V; Munarini A; Bianchi F; Belluzzi A; Bazzoli F; Ricciardiello L
Carcinogenesis; 2014 Oct; 35(10):2314-20. PubMed ID: 25123131
[TBL] [Abstract][Full Text] [Related]
2. Cyclin D1 degradation and p21 induction contribute to growth inhibition of colorectal cancer cells induced by epigallocatechin-3-gallate.
Zhang X; Min KW; Wimalasena J; Baek SJ
J Cancer Res Clin Oncol; 2012 Dec; 138(12):2051-60. PubMed ID: 22814742
[TBL] [Abstract][Full Text] [Related]
3. Significance of mTOR signaling and its inhibitor against cancer stem-like cells in colorectal cancer.
Cai Z; Ke J; He X; Yuan R; Chen Y; Wu X; Wang L; Wang J; Lan P; Wu X
Ann Surg Oncol; 2014 Jan; 21(1):179-88. PubMed ID: 23907312
[TBL] [Abstract][Full Text] [Related]
4. Sex determining region Y-box 2 inhibits the proliferation of colorectal adenocarcinoma cells through the mTOR signaling pathway.
Liu H; Du L; Wen Z; Yang Y; Li J; Dong Z; Zheng G; Wang L; Zhang X; Wang C
Int J Mol Med; 2013 Jul; 32(1):59-66. PubMed ID: 23599173
[TBL] [Abstract][Full Text] [Related]
5. Epigallocatechin gallate (EGCG), a major component of green tea, is a dual phosphoinositide-3-kinase/mTOR inhibitor.
Van Aller GS; Carson JD; Tang W; Peng H; Zhao L; Copeland RA; Tummino PJ; Luo L
Biochem Biophys Res Commun; 2011 Mar; 406(2):194-9. PubMed ID: 21300025
[TBL] [Abstract][Full Text] [Related]
6. Krill oil extract suppresses cell growth and induces apoptosis of human colorectal cancer cells.
Jayathilake AG; Senior PV; Su XQ
BMC Complement Altern Med; 2016 Aug; 16(1):328. PubMed ID: 27576529
[TBL] [Abstract][Full Text] [Related]
7. The inhibitory effect of ECG and EGCG dimeric procyanidins on colorectal cancer cells growth is associated with their actions at lipid rafts and the inhibition of the epidermal growth factor receptor signaling.
Zhu W; Li MC; Wang FR; Mackenzie GG; Oteiza PI
Biochem Pharmacol; 2020 May; 175():113923. PubMed ID: 32217102
[TBL] [Abstract][Full Text] [Related]
8. PAC exhibits potent anti-colon cancer properties through targeting cyclin D1 and suppressing epithelial-to-mesenchymal transition.
Al-Qasem A; Al-Howail HA; Al-Swailem M; Al-Mazrou A; Al-Otaibi B; Al-Jammaz I; Al-Khalaf HH; Aboussekhra A
Mol Carcinog; 2016 Mar; 55(3):233-44. PubMed ID: 25641341
[TBL] [Abstract][Full Text] [Related]
9. Atractylenolide I inhibits colorectal cancer cell proliferation by affecting metabolism and stemness via AKT/mTOR signaling.
Wang K; Huang W; Sang X; Wu X; Shan Q; Tang D; Xu X; Cao G
Phytomedicine; 2020 Mar; 68():153191. PubMed ID: 32135457
[TBL] [Abstract][Full Text] [Related]
10. PI3K/mTOR inhibition upregulates NOTCH-MYC signalling leading to an impaired cytotoxic response.
Shepherd C; Banerjee L; Cheung CW; Mansour MR; Jenkinson S; Gale RE; Khwaja A
Leukemia; 2013 Mar; 27(3):650-60. PubMed ID: 23038273
[TBL] [Abstract][Full Text] [Related]
11. The omega-3 polyunsaturated fatty acid eicosapentaenoic acid inhibits mouse MC-26 colorectal cancer cell liver metastasis via inhibition of PGE2-dependent cell motility.
Hawcroft G; Volpato M; Marston G; Ingram N; Perry SL; Cockbain AJ; Race AD; Munarini A; Belluzzi A; Loadman PM; Coletta PL; Hull MA
Br J Pharmacol; 2012 Jul; 166(5):1724-37. PubMed ID: 22300262
[TBL] [Abstract][Full Text] [Related]
12. The Effect of Different Treatments of (-)-Epigallocatechin-3-Gallate on Colorectal Carcinoma Cell Lines.
Ding YP; Gao ZL; Chen BC; Rakariyatham K; Suo HY; Tong HR; Xiao H
Nutr Cancer; 2018 Oct; 70(7):1126-1136. PubMed ID: 30513211
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate.
Liang YC; Lin-Shiau SY; Chen CF; Lin JK
J Cell Biochem; 1999 Oct; 75(1):1-12. PubMed ID: 10462699
[TBL] [Abstract][Full Text] [Related]
14. In vitro mechanism of action for the cytotoxicity elicited by the combination of epigallocatechin gallate and raloxifene in MDA-MB-231 cells.
Stuart EC; Jarvis RM; Rosengren RJ
Oncol Rep; 2010 Sep; 24(3):779-85. PubMed ID: 20664987
[TBL] [Abstract][Full Text] [Related]
15. Embelin inhibits growth and induces apoptosis through the suppression of Akt/mTOR/S6K1 signaling cascades.
Kim SW; Kim SM; Bae H; Nam D; Lee JH; Lee SG; Shim BS; Kim SH; Ahn KS; Choi SH; Sethi G; Ahn KS
Prostate; 2013 Feb; 73(3):296-305. PubMed ID: 22887478
[TBL] [Abstract][Full Text] [Related]
16. An α-acetoxy-tirucallic acid isomer inhibits Akt/mTOR signaling and induces oxidative stress in prostate cancer cells.
El Gaafary M; Büchele B; Syrovets T; Agnolet S; Schneider B; Schmidt CQ; Simmet T
J Pharmacol Exp Ther; 2015 Jan; 352(1):33-42. PubMed ID: 25316122
[TBL] [Abstract][Full Text] [Related]
17. 5-Aminosalicylic acid inhibits cell cycle progression in a phospholipase D dependent manner in colorectal cancer.
Baan B; Dihal AA; Hoff E; Bos CL; Voorneveld PW; Koelink PJ; Wildenberg ME; Muncan V; Heijmans J; Verspaget HW; Richel DJ; Hardwick JC; Hommes DW; Peppelenbosch MP; van den Brink GR
Gut; 2012 Dec; 61(12):1708-15. PubMed ID: 22187071
[TBL] [Abstract][Full Text] [Related]
18. The PI3K/Akt pathway is involved in procyanidin-mediated suppression of human colorectal cancer cell growth.
Choy YY; Fraga M; Mackenzie GG; Waterhouse AL; Cremonini E; Oteiza PI
Mol Carcinog; 2016 Dec; 55(12):2196-2209. PubMed ID: 26774105
[TBL] [Abstract][Full Text] [Related]
19. Sustained antitumor activity by co-targeting mTOR and the microtubule with temsirolimus/vinblastine combination in hepatocellular carcinoma.
Zhou Q; Lui VW; Lau CP; Cheng SH; Ng MH; Cai Y; Chan SL; Yeo W
Biochem Pharmacol; 2012 May; 83(9):1146-58. PubMed ID: 22285225
[TBL] [Abstract][Full Text] [Related]
20. Potential mechanisms for the synergistic cytotoxicity elicited by 4-hydroxytamoxifen and epigallocatechin gallate in MDA-MB-231 cells.
Stuart EC; Larsen L; Rosengren RJ
Int J Oncol; 2007 Jun; 30(6):1407-12. PubMed ID: 17487361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
